Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Lewy Body Dementia Market Be Worth By 2029?

The market size for Lewy body dementia has seen a significant upsurge in the recent past. Its growth trajectory suggests it will boost from $1.12 billion in 2024 to $1.2 billion in 2025, recording a compound annual growth rate (CAGR) of 7.2%. This impressive growth during the historical period is linked to the increase in the ageing populace, heightening awareness about neurodegenerative diseases, a surge in healthcare spending, refinement in diagnostic standards, and the sanctioning of drugs for dementia by regulatory bodies.

Expectations are high for robust growth in the lewy body dementia market in the coming years. With a compound annual growth rate (CAGR) of 7.1%, the market size is forecasted to reach $1.58 billion in 2029. The surge within the forecast period can be linked to an increased prevalence of dementia, larger investments in R&D, a higher demand for early detection, broader telemedicine adoption, and a shift towards personalized medicine. Key trends for the forecast period include the development of targeted treatments, the broadening of clinical trials, advancements in diagnostic methods, technological progress, and a focus on groundbreaking therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp

What External And Internal Drivers Are Influencing The Lewy Body Dementia Market?

The increase in brain-related disorders is predicted to fuel the development of the lewy body dementia market. These disorders encompass a variety of conditions that impact the structure and function of the brain, often resulting in cognitive decline, memory impairment, and changes in behavior. A rise in the incidence of these disorders can be attributed to factors such as ageing, genetic factors, and environmental effects. As the prevalence of these disorders heightens, so does the need for improved treatments and early detection for lewy body dementia, thereby encouraging research, funding, and innovation and paving the way for significant progress in diagnosis and treatment for LBD. For example, in October 2023, reports from the World Federation of Neurology, a UK-based conglomerate of national neurological societies, revealed that neurological conditions affect over 40% of the world’s population, a number that is predicted to nearly double by 2050. Consequently, the increasing occurrence of brain-related disorders will stimulate the expansion of the lewy body dementia market.

What Segmentation Insights Are Provided In The Lewy Body Dementia Market Research?

The lewy body dementiamarket covered in this report is segmented –

1) By Diagnosis: Clinical Diagnosis; Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors; Antipsychotics; Antidepressants; Other Medications

3) By End-User: Hospitals; Specialty Clinics; Long-Term Care Facilities; Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing; Neurological Examination; Medical History Review; Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers; Imaging Biomarkers (PET, MRI); Genetic Biomarkers; Blood-Based Biomarkers

Which Trends Are Likely To Redefine Growth Paths In The Lewy Body Dementia Market?

Key players in the lewy body dementia market are dedicating resources to research and development to discover better treatment options for neurodegenerative diseases. Research investment includes financial backing for scientific projects aimed at finding innovative therapies or improving existing ones. In March 2023, the US-based National Institute on Aging awarded $21 million in funding to support drug development for Lewy Body Dementia (LBD). The University of Miami Miller School of Medicine is using the grant to begin a Phase 2b clinical trial of neflamapimod following positive early-phase results.

Who Are The Leading Companies Driving The Lewy Body Dementia Market?

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer’s Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Lewy Body Dementia Market?

North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21213&type=smp

Browse Through More Reports Similar to the Global Lewy Body Dementia Market 2025, By The Business Research Company

Lewy Body Dementia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Behavioral And Mental Health Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Behavioral Biometrics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-biometrics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model